ÓÀÀÖ¸ß60net

ͼƬÃû³Æ

ÐÂÎÅ×ÊѶ

ÓÀÀÖ¸ß60netÔ­ÑÐÒ©MCR»·ëÄÆô·¢ÌÇÄò²¡ÊÓÍøĤ²¡±ä¶àͨ·ҽÖÎÐÂÕ½Êõ£¬Í»ÆÆ¿¹VEGFÒ©Îï¾ÖÏÞ½ø¾üDZÔÚÊý°ÙÒÚÐÂÈü·

ÈÕÆÚ£º

2026Äê04ÔÂ02ÈÕ 15:00

ÌÇÄò²¡ÊÓÍøĤ²¡±ä£¨DR£©ÊÇÌÇÄò²¡×î³£¼ûÇÒÑϳÁµÄ΢Ѫ¹Ü²¢·¢Ö¢Ö®Ò»£¬Ò²ÊǸ÷´ºÇïÈËȺ£¨Ô̺¬¶ùͯ¡¢¹¤×÷³ÉÄêÈ˺ÍÀÏÄêÈË£©ÖØÒªµÄÖÂäԭÒò1¡£2020Ä꣬ȫÇòÓг¬¹ý1.03ÒÚÈËÊܵ½ÌÇÄò²¡ÊÓÍøĤ²¡±äµÄÓ°Ï죬Ԥ¼Æµ½2045ÄêÕâÒ»Êý×Ö½«ÉÏÉýµ½1.61ÒÚÈË1¡£ÕâÖðÒ»Á¬¶àÄêµÄÁÙ´²ðó¼²£¬Õý±»Ò»ÏîÖйúÔ­´´Í»ÆÆËùº³¶¯¡£½üÈÕ£¬¾ÝϤÓÀÀÖ¸ß60net£¨ÒÔϼò³Æ“ÓÀÀÖ¸ß60net”£©×ÔÖ÷Ñз¢µÄ´´ÐÂÓ×·Ö×Ó»·ëÄÒ©ÎMCR»·ëÄ£©ÔÚÌÇÄò²¡ÊÓÍøĤ²¡±äÒ½ÖÎÁìÓò»ñµÃÁÙ´²Ç°³Á´óÍ»ÆÆ¡£

Ò»¡¢ÌÇÄò²¡ÊÓÍøĤ²¡±äµÄÒ½ÖÎÀ§¾³

ÌÇÄò²¡ÊÓÍøĤ²¡±äÊÇÒ»ÖÖ½øÕ¹ÐÔÑÛ²¿¼²²¡£¬³Ö¾Ã¸ßѪÌǻᵼÖÂÊÓÍøĤ΢Ѫ¹ÜΣÏÕ£¬Òý·¢ÊÓÍøĤȱѪȱÑõ£¬½ø¶øÍƽø²¡ÀíÐÔÐÂÉúѪ¹ÜÐγÉ£¬Ôì³ÉÊÓÍøĤÔöÖ³ÐÔ²¡±ä2¡£Ä¿Ç°£¬¿¹VEGFÒ©ÎïºÍ¼¤¹â¹âÄýÊõÊÇÒ½ÖÎDRµÄ½ð³ß¶ÈÁÆ·¨£¬µ«´æÔÚ±ØҪƵÈÔÑÛÄÚ×¢Éä¡¢²¿ÃÅ»¼ÕßÓ¦´ðÇ·°²µÈÎÊÌ⣬ؽÐèÐÂÐÍÒ½ÖÎÕ½Êõ1¡£

½üÄêÀ´µÄ×êÑз¢ÏÖ£¬ºÚƤÖÊËØϵͳ£¨Melanocortin System£©ÔÚµ÷½ÚÑ×Ö¢·´Ó³¡¢Íƽø×éÖ¯½¨¸´ºÍά³ÖÄÚ»·¾³²»±ä·½Ãæ²ûÑï¹Ø¼ü×÷ÓÃ3£¬ÎªDRÒ½ÖÎÌṩÁËÐÂ˼·¡£

¶þ¡¢ÓÀÀÖ¸ß60netMCR»·ëÄ£º¶ÔÊÓÍøĤ½á¹¹±£»¤³ÉЧÏÔÖø

ÓÀÀÖ¸ß60netÑз¢µÄMCR»·ëÄÔÚDB/DBÌÇÄò²¡Ó×ÊóÄ£ÐÍÖвû·¢³öÏÔÖøµÄÊÓÍøĤ±£»¤×÷Óá£

 

5b06997c-738d-44d5-a16e-5cf1948b90f0

 

³¢ÊÔÁ˾ÖÏÔʾ£¬DB/DBÄ£ÐÍÓ×ÊóµÄÄں˲㣨INL£©ºÍ±íºË²ã£¨ONL£©ºñ¶ÈÏÔÖø±ä±¡£¬ÕâÊÇÌÇÄò²¡ÒýÆðÊÓÍøĤ±äÐԵĵäÐÍÌصã¡£¶ø¾­¹ýMCR»·ëÄÒ½Öκó£¬ÊÓÍøĤ½á¹¹µÃµ½ÏÔÖø¸ÄÉÆ£º

1. MCR»·ëĵͼÁÁ¿×éºÍ¸ß¼ÁÁ¿×éÏÔʾ¼ÁÁ¿ÒÀÀµÐÔµÄÊÓÍøĤ½á¹¹¸´Ô­£»

2. MCR»·ëĸ߼ÁÁ¿×éµÄONLºñ¶È¸´Ô­¿¿½üÕý³£Ë®Æ½¡£

Èý¡¢¶à³Á»úÔìЭͬ×÷ÓÃ

ÓÀÀÖ¸ß60netMCR»·ëĵÄÖ÷ÌâÓÅÊÆÔÚÓÚÆä¶à°Ðµã×÷ÓûúÔì¡£ËüÄ£ÄâÁËÄÚÔ´ÐÔºÚƤÖÊËØ£¨Èçα- MSH£©µÄÉúÀíÖ°ÄÜ£¬Í¨¹ý¼¤»îÑÛÖеĺÚƤÖÊËØÊÜÌ壬´ÓÑ×Ö¢¡¢Ñª¹Ü¡¢·®ÀéºÍÉñ¾­µÈ¶à¸ö¹Ø¼ü»·½ÚЭͬ²ûÑï×÷ÓÃ1, 4¡£

 

a1228453-21da-470c-908a-9e20df4f7b8f

 

ǿЧ¿¹Ñ×ÓëÃâÒßµ÷½Ú

ÌÇÄò²¡ÊÓÍøĤ²¡±äÐÔÖÊÉÏÊÇÒ»ÖÖÂýÐԵͶÈÑ×Ö¢ÐÔ¼²²¡¡£×êÑÐ֤ʵ£¬¼¤»îMCR£¬³ö¸ñÊÇMC1R£¬¿ÉÄÜÏÔÖøÒÖÔìºËÒò×ÓκB£¨NF-κB£©µÈ¹Ø¼ü´ÙÑ×ÐźÅͨ·µÄ»î»¯5¡£Õâµ¼Ö¶àÖÖ´ÙÑ×Òò×Ó£¨ÈçTNF-α, IL-1β, IL-6£©ºÍÇ÷»¯Òò×Ó£¨ÈçMIP-1α, MIP-2£©µÄ±í°×ϵ÷4¡£¸ü³ÁÒªµÄÊÇ£¬MCR¼¤°º¼ÁÄÜÓÕµ¼ÓµÓп¹Ñ×Ö°Äܵĵ÷½ÚÐÔTϸ°û£¨Treg£©µÄÌìÉú£¬²¢Íƽø¿¹Ñ×ϸ°ûÒò×ÓIL-10µÄ±í°×£¬´Ó¶ø½«ÃâÒß·´Ó³´Ó·ÛËéÐԵĴÙÑ×״̬תÏò±£»¤ÐԵĿ¹Ñ׺ͽ¨¸´×´Ì¬4, 5¡£´Ë±í£¬ÔÚÌÇÄò²¡ÊÓÍøĤ²¡±äÄ£ÐÍÖУ¬MCR¼¤°º¼Á»¹±»Ö¤Ã÷Äܹ»Íƽø¾ÞÊÉϸ°û´Ó´ÙÑ×µÄM1±íÐÍÏò¿¹Ñס¢´Ù½¨¸´µÄM2±íÐͼ«»¯£¬ÕâÓÐÖúÓÚÑ×Ö¢µÄÏûÍ˺Í×éÖ¯½¨¸´4¡£

 ¿¹Ñª¹ÜÌìÉúÓë¼õÇáÉø©

³ýÁËÒÖÔìÑ×Ö¢£¬MCR¼¤°º¼Á¿ÉÄÜÖ±½Ó×÷ÓÃÓÚѪ¹Üϵͳ¡£×êÑÐÅú×¢£¬¼¤»îMC4RÄܹ»Þ׿¹ÊÓÍøĤ΢Ѫ¹ÜÄÚƤϸ°ûµÄ¸ßͨ͸ÐÔ5¡£Í¬Ê±£¬¼¤°ºMC1RÄÜÏÔÖø½µµÍÊÓÍøĤÖÐѪ¹ÜÄÚƤ³É³¤Òò×Ó£¨VEGF£©µÄˮƽ£¬ÕâÊÇÇý¶¯²¡ÀíÐÔÐÂÉúѪ¹ÜÐγɺÍѪ¹ÜÉø©µÄ¹Ø¼üÒò×Ó4¡£ÕâÖÖͨ¹ýµ÷½ÚÄÚÔ´ÐÔͨ·À´ÒÖÔìVEGFµÄ¹ÖÒì»úÔ죬ÓëÏÖÓеĿ¹VEGFÒ©ÎïÐγɻ¥²¹£¬¿ÉÄÜΪ½â¾ö¿¹VEGFÒ½ÖÎÄÍÒ©ÐÔÎÊÌâÌṩÐÂÕ½Êõ¡£

 ²»±äѪ-ÊÓÍøĤ·®Àé

Ѫ-ÊÓÍøĤ·®ÀéµÄ·ÛËéÊÇÌÇÄò²¡ÊÓÍøĤ²¡±äѪ¹ÜÉø©ºÍÊÓÍøĤˮÖ׵IJ¡Àí»ù´¡¡£MCR¼¤»î¿ÉÏÔÖøÔö³¤ÊÓÍøĤÖÐçÇÃÜÏνӵ°°×£¨ÈçOccludin£©µÄ±í°×£¬´Ó¶ø´Ó½á¹¹ÉϼӹÌѪ-ÊÓÍøĤ·®À飬Ï÷¼õѪ½¬³É·ÖµÄÉø©4¡£

Ö±½Óϸ°û±£»¤Ó뿹µòÍö

MCRµÄϸ°û±£»¤×÷Óó¬¹ýÁËѪ¹ÜºÍÑ×֢ϸ°û£¬Ö±½Ó»Ý¼°ÊÓÍøĤÉñ¾­Ôª¡£α-MSHÒѱ»Ö¤Ã÷¿ÉÄÜͨ¹ý¼¤»îMC1R¼°ÆäÏÂÓεÄAkt/mTORºÍErk1/2 MAPKÐźÅͨ·£¬±£»¤ÊÓÍøĤɫËØÉÏƤϸ°ûÃâÊÜÑõ»¯Ó¦¼¤ÓÕµ¼µÄµòÍö5¡£ÔÚȱѪ/ÔÙ¹àעΣÏÕÄ£ÐÍÖУ¬MCR¼¤°º¼ÁÏÔʾ³ö¶ÔÊÓÍøĤÉñ¾­½Úϸ°ûµÄÏÔÖø±£»¤×÷Óã¬Ï÷¼õϸ°ûµòÍö£¬Õâ¶ÔÓÚÔ¤·ÀÌÇÄò²¡ÊÓÍøĤ²¡±äÖеÄÉñ¾­±äÐÔÖÁ¹Ø³ÁÒª¡£

ËÄ¡¢Ô¶¾°Õ°Íû

ÌÇÄò²¡ÊÓÍøĤ²¡±äµÄÒ½ÖÎÕý´¦ÔÚÒ»¸öתÐÍÆÚ£¬´Óµ¥Ò»µÄVEGFÒÖÔìÏò¶à°Ðµã¡¢È«·½Î»±£»¤µÄ·½Ïò·¢Õ¹¡£ÓÀÀÖ¸ß60netµÄMCR»·ëÄÒ©Îïƾ½èÆä¹ÖÒìµÄ×÷ÓûúÔìºÍÁîÈ˹ÄÀøµÄÁÙ´²Ç°Êý¾Ý£¬ÓÐÍû³ÉΪÕâÒ»ÁìÓòµÄ³Á°õ²úÆ·£¬ÎªÈ«ÇòÊýÒÚDR»¼Õß´øÀ´ÐµÄÒ½ÖÎÑ¡Ôñ¡£

ÎÄÕÂÆðÔ´ÓÚҩʱÆÚ¹«¼ÒºÅ

²Î¿¼Îļþ

1. Seo, H., Park, S. J., & Song, M. (2025). Diabetic Retinopathy (DR): Mechanisms, Current Therapies, and Emerging Strategies. Cells, 14(5), 376. https://doi.org/10.3390/cells14050376

2. áÓÖÝÉòÊÏÑÛ¿ÆÒ½Ôº£¨2024£©. ÌÇÄò²¡ÐÔÊÓÍøĤ²¡±ä¿ÆÆÕ. ΢ÐŹ«¼ÒºÅ. Available at:https://mp.weixin.qq.com/s?__biz=MzA5NDI4NTcyNw==&mid=2653585500&idx=1&sn=87cf362b3300a3db891c4c19b8296833&chksm=8a0f495e1bf34e32bdd0e087b3d55b6541aac5cd462a1dacdd8b0a2fc8e71fea61b44b2d1bb7&scene=27 £¨Accessed: September 28, 2025£©

3. Kayne, P. et al. (2025). Activating the Melanocortin System Resolves Inflammation, Reduces VEGF Signaling in Diabetic Retinopathy (DR), and Provides Retinal Ganglion Cell (RGC) Protection. Available at:https://palatin.com/wpcontent/uploads/2025/05/PosterPTN_PL9654_Diabetic_RetinopathyARVO_2025050825.pdf (Accessed: September 28, 2025)

4. Rossi, S., Maisto, R., Gesualdo, C., Trotta, M. C., Ferraraccio, F., Kaneva, M. K., Getting, S. J., Surace, E., Testa, F., Simonelli, F., Grieco, P., Merlino, F., Perretti, M., D'Amico, M., & Di Filippo, C. (2016). Activation of Melanocortin Receptors MC 1 and MC 5 Attenuates Retinal Damage in ExperimentalDiabeticRetinopathy. Mediatorsofinflammation,2016, 7368389. https://doi.org/10.1155/2016/7368389

5. Wang, S., Kahale, F., Naderi, A., Surico, P. L., Yin, J., Dohlman, T., Chen, Y., & Dana, R. (2024). Therapeutic Effects of Stimulating the Melanocortin Pathway in Regulating Ocular Inflammation and Cell Death.Biomolecules,14(2),169. https://doi.org/10.3390/biom14020169

ÓйØÍƼö